Please assess the completion status of the following clinical trial:

Trial Title: NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pulmonary nodules undergoing thoracoscopy or thoracotomy~* Esophageal cancer patients who underwent radical surgery~* Preoperative liver function is normal~* No indocyanine green and iodine allergies, and indocyanine green skin test negative~* Volunteered to participate in this study and signed informed consent in this study~Exclusion Criteria:~* Preoperative liver dysfunction~* Indocyanine green or iodine allergies, or indocyanine green skin test positive~* Not combined with other well-controlled comorbidities~* Clinicians considered unsuitable for enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Indocyanine green (Type: EXPERIMENTAL): This group of patients under general anesthesia to accept conventional thoracoscopy or thoracotomy. Before systematic lymphadenectomy, four-point of ICG with 10mg was injected in normal lung tissue around the tumor. After 3-5 minutes, fluorescence and white-light images were collected and recorded in real-time. With the guidance of intraoperative images, all fluorescent lymph nodes were removed and sent to routine pathological confirmation.

Based on this trial design, predict the completion outcome and termination type (if applicable).